GlassScriptPhysician profile
Eric P Sabonghy
NPI 1023093291
$9,508.20
in general payments reported to CMS, 2019-2025
13 companies · $425 in 2025
The $425 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,137 · 2020: $1,908 · 2021: $190 · 2022: $2,491 · 2023: $700 · 2024: $1,657 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,627 · Food and Beverage: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,627.34 |
| Food and Beverage | $1,155.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,376.28 | 2019-2023 | |
| Shoulder Innovations, INC. | $1,627.34 | 2024 | Inset System |
| Encore Medical, LP | $1,369.69 | 2019 | |
| Medinc of Texas | $1,032.66 | 2022-2023 | |
| Lima USA, INC. | $714.28 | 2020 | |
| Sanara Medtech INC. | $388.89 | 2023-2025 | Celleraterx, Celleraterx |
| Smith+Nephew, INC. | $351.91 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Horizon Therapeutics Plc | $317.75 | 2019-2022 | |
| Stryker Corporation | $137.59 | 2022-2025 | Aequalis Perform Reversed |
| Ferring Pharmaceuticals INC. | $96.58 | 2022-2025 | Euflexxa |
| Moximed, INC | $52.16 | 2025 | Misha Knee System, Small, Left |
| Vericel Corporation | $22.47 | 2025 | Maci |
| Integra Lifesciences Corporation | $20.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Sabonghy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.